|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of BioCryst Pharmaceuticals (NASDAQ: BCRX) through any online brokerage.
The latest price target for BioCryst Pharmaceuticals (NASDAQ: BCRX) was reported by Oppenheimer on December 10, 2021. The analyst firm set a price target for 16.00 expecting BCRX to rise to within 12 months (a possible 7.60% upside). 10 analyst firms have reported ratings in the last year.
The stock price for BioCryst Pharmaceuticals (NASDAQ: BCRX) is $14.87 last updated Fri Jan 28 2022 21:00:02 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for BioCryst Pharmaceuticals.
BioCryst Pharmaceuticals’s $Q4 earnings are confirmed for after-market on February 24, 2022.
There is no upcoming split for BioCryst Pharmaceuticals.
BioCryst Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.